Results 81 to 90 of about 171,578 (191)

Longitudinal trends in Gamma Knife radiosurgery utilization across multiple technological generations: A Single‐Institution Observational Study

open access: yesJournal of Applied Clinical Medical Physics, Volume 27, Issue 10, October 2026.
Abstract Background Gamma Knife radiosurgery (GKRS) has been a foundational modality for the treatment of intracranial diseases for several decades, with successive platform generations introducing substantial technological advancements. Improvements in source configuration, patient positioning systems, imaging guidance, and immobilization techniques ...
Daniel El Basha   +11 more
wiley   +1 more source

ATF6‐mediated GTPase RHOQ promotes liver cancer progression via enhancing aerobic glycolysis through PAK1 phosphorylation

open access: yesClinical and Translational Medicine, Volume 16, Issue 10, October 2026.
• RHOQ is a novel direct transcriptional target of ATF6 in HCC. • High RHOQ expression is associated with unfavourable clinicopathological features and poorer PFS. • RHOQ drives HCC progression via PAK1 activation and aerobic glycolysis. • Combining the PAK1‐specific inhibitor IPA‐3 with GPC3‐targeted CAR T‐cell therapy produces a potent synergistic ...
Yuange Zheng   +5 more
wiley   +1 more source

Usefulness of the 3D virtual visualization surgical planning simulation and 3D model for endoscopic endonasal transsphenoidal surgery of pituitary adenoma: Technical report and review of literature

open access: yesInterdisciplinary Neurosurgery, 2018
The purpose of this research was to investigate the usefulness of three-dimensional print models (3D models) in endoscopic endonasal transsphenoidal surgery (EeTSS) for pituitary adenoma.
Aya Shinomiya, M.D., Ph.D.   +6 more
doaj   +1 more source

Understanding the Symptom Burden of Complex Skull Base Tumors From the Patient's Perspective

open access: yesHead &Neck, Volume 48, Issue 10, Page 2720-2732, October 2026.
ABSTRACT Background Symptom burden of skull base tumor (SBT) patients, especially those undergoing multimodality treatment, is poorly understood. We aim to understand symptom burden in this patient group using the core module the MD Anderson Symptom Inventory (MDASI).
Shirley Y. Su   +8 more
wiley   +1 more source

Dural arteriovenous fistula with isolated acute subdural hematoma

open access: yesAsian Journal of Surgery, 2022
Jianguo Li, Cheng Chen, Peizhi Zhou
doaj   +1 more source

Applications and prospects of artificial intelligence and digital medicine in pediatric nasal skull base tumors

open access: yesPediatric Investigation, Volume 10, Issue 5, Page 432-444, October 2026.
Pediatric nasal skull base tumors present diagnostic and therapeutic challenges due to their deep location, nonspecific symptoms, and the narrow nasal cavity in children. Although artificial intelligence (AI) and digital medicine have advanced early diagnosis, multidisciplinary treatment, and prognosis, their application in these rare tumors remains ...
Xiuping Wu   +5 more
wiley   +1 more source

The Importance of Immunohistochemical Analysis in Silent Pituitary Adenoma [PDF]

open access: yes, 2018
Pituitary adenoma contributes to 15% of all intracranial neoplasm. It is usually following benign course and some of them are silent (asymptomatic clinically, but hormone-secreting).
Stevina, Nathania Victoria   +3 more
core   +1 more source

Interference by Design: Embedding Moiré Beat‐Field Geometry into Variational Quantum Circuits for Brain Tumour Diagnosis

open access: yesAdvanced Quantum Technologies, Volume 9, Issue 10, October 2026.
What if the key to efficient quantum diagnosis lies not in the circuit, but in the geometry feeding it? Embedding Moiré beat‐field interference into a variational quantum circuit sharpens brain tumour class boundaries, lifting four‐class MRI accuracy to 92.5% and halving circuit deptheach claim validated on real quantum hardware.
Akoramurthy B   +2 more
wiley   +1 more source

GRAVES’ DISEASE WITH NON-FUNCTIONING PITUITARY ADENOMA [PDF]

open access: yes, 2020
Pituitary adenoma may be associated with hyperthyroidism if there is excess production of thyroid stimulating hormone (TSH). However, the occurrence of Graves’ disease and this slow-growing benign pituitary tumor (1% of functioning adenomas producing TSH)
Zakaria Kadir   +3 more
core  

Acromegaly with No Evidence of Pituitary Adenoma or Ectopic Source [PDF]

open access: yes, 2017
Acromegaly is caused by the uncontrolled hypersecretion of growth hormone (GH) and secondary increases of insulin-like growth factor-1. More than 95% of patients with acromegaly have a growth hormone-secreting pituitary adenoma.
Durmaz, Senay Arikan   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy